Barrett's esophagus screening
|
Barrett's Esophagus Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Barrett's esophagus screening On the Web |
|
American Roentgen Ray Society Images of Barrett's esophagus screening |
|
Risk calculators and risk factors for Barrett's esophagus screening |
Barret's esophagus is a major risk factor for development of esophageal adenocarcinoma. After diagnosis, regular surveillance is needed based on the grade of dyaplasia.
Overview
- Weak recommendation, moderate-quality evidence: screening in patients with multiple risk factors for esophageal adenocarcinoma:
- Age: > 50 years old
- Sex: male
- Race: white
- Other: chronic GERD, hiatal hernia, elevated BMI (body mass index),and intraabdominal distribution of body fat.
- Strong recommendation, low-quality evidence:
- Recommend against screening general population with GERD and no risk factors.[1]
Surveillance
Weak recommendation, moderate-quality evidence: Endoscopic surveillance in patients with Barrett's esophagus The following intervals are recommended:
- No dysplasia: 3–5 years.
- Low-grade dysplasia: 6–12 months.
- High-grade dysplasia in the absence of eradication therapy: 3 months.[1]